Pelvic floor and sexual health in women with systemic sclerosis
Part of Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study looks at how systemic sclerosis (a chronic autoimmune disease that can affect connective tissues) might relate to pelvic floor problems and sexual health issues in women. It compares women who have the condition with healthy women to find patterns that could lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 64 years old.
- You have been diagnosed with systemic sclerosis.
- You are sexually active and have not gone through menopause.
- You do not have other current or past rheumatologic (autoimmune joint/connective tissue) diseases besides systemic sclerosis.
- You do not have active urological or gynecological conditions (like bladder or reproductive system problems).
- You have not had surgeries related to urinary or reproductive organs (except C-section).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how systemic sclerosis affects daily function and mental well-being, including social and emotional factors. It may help patients understand their condition better.
This trial tests whether special cells from umbilical cord (UC-MSC) can help treat systemic sclerosis—a disease that causes skin and organ hardening. If you have early systemic sclerosis that hasn't improved enough with standard treatments, this study may offer a new option.
This research study uses special lab-grown stem cells to understand how systemic sclerosis (a disease that hardens skin and organs) develops and progresses. By studying cells from patients with different types of systemic sclerosis and healthy relatives, researchers hope to find new ways to treat or prevent the disease.
This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.
This trial tests an investigational drug called efgartigimod in people with systemic sclerosis (scleroderma). The goal is to see if it can safely reduce skin thickening and improve overall health. You might qualify if your skin is moderately affected and you have certain antibodies in your blood.
This trial studies pelvic floor problems (like bladder, bowel, or sexual issues) in people with multiple sclerosis. It aims to understand how these problems affect patients and find better ways to help.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.